Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

Keyphrases

• Body Mass Index 66%
• Cell Response 16%
• Diabetic Subjects 100%
• Dysmetabolism 100%
• Early Signs 100%
• Glucagon 66%
• Glucose Infusion 33%
• Hyperglucagonemia 100%
• Incretin Effect 100%
• Incretin Hormones 16%
• Insulin Resistance 16%
• Intravenous Glucose 33%
• Lean Patients 16%
• Normal Glucose Tolerance 83%
• Obese Men 33%
• Obese Patients 16%
• Obese Subjects 50%
• Obesity 100%
• Oral Glucose Tolerance Test 50%
• Pathophysiology 16%
• Standard Error of the Mean 16%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Type 2 Diabetes Mellitus Patients 16%
• Type 2 Diabetic 100%
• Type 2 Diabetic Patients 50%

Biochemistry, Genetics and Molecular Biology

• Body Mass 66%
• Glucagon 50%
• Glucagon Blood Level 16%
• Glucose Test 50%
• Glucose Tolerance Test 50%
• Incretin 100%
• Normal Human 16%